Mirae Asset Global Investments Co., Ltd. Liva Nova PLC Transaction History

Mirae Asset Global Investments Co., Ltd.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$48.6 - $57.12 $142,592 - $167,590	-2,934 Reduced 10.12%	26,047 $1.46 Million
Q4 2023 Jan 24, 2024	BUY	$43.45 - $53.66 $77,297 - $95,461	1,779 Added 6.54%	28,981 $1.5 Million
Q3 2023 Oct 26, 2023	BUY	$50.12 - $58.87 $27,265 - $32,025	544 Added 2.04%	27,202 $1.44 Million
Q2 2023 Aug 10, 2023	BUY	$42.28 - $51.43 $25,833 - $31,423	611 Added 2.35%	26,658 $1.37 Million
Q1 2023 May 04, 2023	BUY	$40.84 - $58.14 $34,142 - $48,605	836 Added 3.32%	26,047 $1.14 Million
Q4 2022 Feb 09, 2023	BUY	$43.88 - $56.16 $40,150 - $51,386	915 Added 3.77%	25,211 $1.4 Million
Q3 2022 Nov 10, 2022	BUY	$48.37 - $66.5 $308,165 - $423,671	6,371 Added 35.54%	24,296 $1.23 Million
Q2 2022 Jul 26, 2022	BUY	$57.25 - $86.63 $1.03 Million - $1.55 Million	17,925 New	17,925 $1.12 Million
Q2 2018 Aug 14, 2018	SELL	$81.75 - $105.37 $1.32 Million - $1.71 Million	-16,200 Closed	0 $0
Q4 2017 Feb 12, 2018	SELL	$71.8 - $88.21 $1.08 Million - $1.32 Million	-15,000 Reduced 48.08%	16,200 $1.3 Million
Q3 2017 Nov 08, 2017	BUY	$60.32 - $70.06 $1.88 Million - $2.19 Million	31,200	31,200 $2.19 Million

261

52.9M

316K

127K

Ticker LIVN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 53,545,700
Market Cap $2.52B
Description
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.